1. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. Patients With Chronic Heart Failure. 2002;2392–7.
2. Bettencourt P, Azevedo A, Pimenta J, Friões F, Ferreira S, Ferreira A. N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients. 2010;2168–74.
3. Hall JE, Guyton AC. Guyton and Hall Physiology Review. Guyton and Hall Physiology Review. 2011. 171–190 p.
4. TADA H, ITO S, SHINBO G, TADOKORO K, ITO I, HASHIMOTO T, et al. Significance and Utility of Plasma Brain Natriuretic Peptide Concentrations in Patients with Idiopathic Ventricular Arrhythmias. Pacing Clin Electrophysiol [Internet]. 2006;29(12):1395–403.
5. Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-Induced Cardiomyopathies Mechanisms, Recognition, and Management. J Am Coll Cardiol. 2015;66(15):1714–28.
6. Penela D, Van Huls Vans Taxis C, Aguinaga L, Fernández-Armenta J, Mont L, Castel MA, et al. Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: A prospective multicenter study. J Am Coll Cardiol. 2013;62(13):1195–202.
7. Bay M, Kirk V, Parner J, Hassager C, Nielsen H, Krogsgaard K, et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart [Internet]. 2003;89(2):150–4.
8. Muresan L, Petcu A, Muresan C, Rinzis M, Gu-Setu G, Pop D, et al. The role of NT-proBNP in the diagnosis of ventricular arrhythmias in patients with systemic sclerosis. Iran J Public Health. 2017;46(7):906–16.
9. Xu W, Li M, Chen M, Yang B, Wang D, Kong X, et al. Effect of burden and origin sites of premature ventricular contractions on left ventricular function by 7-day Holter monitor. J Biomed Res [Internet]. 2015;29(April):465–74.
10. Mazurek B, Szydłowski L, Giec-Fuglewicz G, Markiewicz-Łoskot G. N-terminal prohormone brain natriuretic peptide-proBNP levels in ventricular arrhythmias in children. Clin Cardiol. 2009;32(12):690–4.
11. Deniz A, Deveci O, Cagliyan CE. Association among tenascin-C and NT-proBNP levels and arrhythmia prevalence in heart failure. 2017;(December).
12. Yu H, Oswald H, Gardiwal A, Lissel C, Klein G. Comparison of N-Terminal Pro-Brain Natriuretic Peptide Versus Electrophysiologic Study for Predicting Future Outcomes in Patients With an Implantable Cardioverter Defibrillator After Myocardial Infarction. Am J Cardiol. 2007;100(4):635–9.
13. Van Huls Van Taxis CFB, Piers SRD, De Riva Silva M, Dekkers OM, Pijnappels DA, Schalij MJ, et al. Fatigue as Presenting Symptom and a High Burden of Premature Ventricular Contractions Are Independently Associated with Increased Ventricular Wall Stress in Patients with Normal Left Ventricular Function. Circ Arrhythmia Electrophysiol. 2015;8(6):1452–9.
14. Sekiguchi Y, Aonuma K, Yamauchi Y, Obayashi T, Niwa A, Hachiya H, et al. Chronic hemodynamic effects after radiofrequency catheter ablation of frequent monomorphic ventricular premature beats. J Cardiovasc Electrophysiol. 2005;16(10):1057–63.
15. Schey KL, Luther JM, Rose KL. HHS Public Access. 2016;13(3):1–21.